Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SGN-STNV |
Synonyms | |
Therapy Description |
SGN-STNV consists of an antibody against Sialyl-Thomsen-nouveau antigen (STn, CD175s) in conjugation with monomethyl auristatin E (MMAE), which may deliver cytotoxicity to STn-expressing tumor cells (PMID: 28281872). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SGN-STNV | SGN STNV|SGNSTNV | SGN-STNV consists of an antibody against Sialyl-Thomsen-nouveau antigen (STn, CD175s) in conjugation with monomethyl auristatin E (MMAE), which may deliver cytotoxicity to STn-expressing tumor cells (PMID: 28281872). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04665921 | Phase I | SGN-STNV | A Study of SGN-STNV in Advanced Solid Tumors | Terminated | USA | ITA | GBR | FRA | ESP | CAN | 0 |